These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 9890038)

  • 1. In ovo vaccination technology.
    Ricks CA; Avakian A; Bryan T; Gildersleeve R; Haddad E; Ilich R; King S; Murray L; Phelps P; Poston R; Whitfill C; Williams C
    Adv Vet Med; 1999; 41():495-515. PubMed ID: 9890038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity to infectious bronchitis in broilers vaccinated against Marek's disease either in ovo or at hatch and against infectious bronchitis at hatch.
    Avakian AP; Wakenell PS; Grosse D; Whitfill CE; Link D
    Avian Dis; 2000; 44(3):536-44. PubMed ID: 11007000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against Marek's disease with cell-free turkey herpesvirus: interference by maternal antibody.
    Calnek W; Smith MW
    Avian Dis; 1972; 16(4):954-7. PubMed ID: 5079883
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody.
    Bublot M; Pritchard N; Le Gros FX; Goutebroze S
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S81-4. PubMed ID: 17560594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of in ovo administration of infectious bursal disease viral vaccines.
    Giambrone JJ; Dormitorio T; Brown T
    Avian Dis; 2001; 45(1):144-8. PubMed ID: 11332475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field safety and efficacy of in ovo administration of HVT + SB-1 bivalent Marek's disease vaccine in commercial broilers.
    Sarma G; Greer W; Gildersleeve RP; Murray DL; Miles AM
    Avian Dis; 1995; 39(2):211-7. PubMed ID: 7677641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal transfer of resistance against development of Marek's disease tumors.
    Eidson CS; Kleven SH; LaCroix VM; Anderson DP
    Avian Dis; 1972 Apr; 16(1):139-52. PubMed ID: 4337310
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA vaccines for poultry: the jump from theory to practice.
    Haygreen L; Davison F; Kaiser P
    Expert Rev Vaccines; 2005 Feb; 4(1):51-62. PubMed ID: 15757473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of infectious bursal disease vaccine viruses in lymphoid tissues after in ovo vaccination of specific-pathogen-free embryos.
    Corley MM; Giambrone JJ; Dormitorio TV
    Avian Dis; 2001; 45(4):897-905. PubMed ID: 11785894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic efficacy of a Marek's disease vaccine in broiler and replacement layer chickens.
    Kilgore RL
    Avian Dis; 1972 Apr; 16(1):72-7. PubMed ID: 4337319
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.
    Rispens BH; van Vloten H; Mastenbroek N; Maas HJ; Schat KA
    Avian Dis; 1972 Apr; 16(1):108-25. PubMed ID: 4337307
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and immunological response to a new mixed vaccine composed of inactivated Newcastle disease virus, inactivated infectious bronchitis virus, and inactivated Hemophilus gallinarum.
    Otsuki K; Iritani Y
    Avian Dis; 1974 Jul; 18(3):297-304. PubMed ID: 4853743
    [No Abstract]   [Full Text] [Related]  

  • 16. The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken.
    Dilaveris D; Chen C; Kaiser P; Russell PH
    Vaccine; 2007 May; 25(19):3792-9. PubMed ID: 17321645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of chickens against Marek's disease with cell-free herpesvirus of turkeys vaccine.
    Eidson CS; Kleven SH
    Am J Vet Res; 1974 Nov; 35(11):1449-53. PubMed ID: 4429246
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus.
    Rispens BH; van Vloten H; Mastenbroek N; Maas JL; Schat KA
    Avian Dis; 1972 Apr; 16(1):126-38. PubMed ID: 4337309
    [No Abstract]   [Full Text] [Related]  

  • 19. Applications in in ovo technology.
    Johnston PA; Liu H; O'Connell T; Phelps P; Bland M; Tyczkowski J; Kemper A; Harding T; Avakian A; Haddad E; Whitfill C; Gildersleeve R; Ricks CA
    Poult Sci; 1997 Jan; 76(1):165-78. PubMed ID: 9037703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
    Gagic M; St Hill CA; Sharma JM
    Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.